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Cystic fibrosis (CF) in non-American black Africans has only 
been described in case reports.  CF was first reported in a 
South African black child with meconium ileus in 1959.1 Ten 
years later Levin and colleagues2 described twins born to a 
Sotho mother and a Zulu father. One twin had meconium ileus, 
the other had pancreatic insufficiency. 
   Not long after the identification of the cystic fibrosis 
transmembrane conductance regulator (CFTR) gene in 1989, 
molecular genetics proved that CF in Africa was a CFTR 
mutation-based disease. A study of 3 CF cases in black South 
Africans included clinical data and the results of a systematic 
investigation of the CFTR gene in each case.3 Four genes had 
the 3120+1G       A mutation that is significantly prevalent 
in African Americans. Another carried a different mutation 
(G1249E) and the last carried a previously unidentified 54 base 
pair deletion in exon 17a.
   Subsequently Padoa and colleagues4 searched for the 
3120+1G       A mutation and 3 other mutations found in 
African Americans, among 208 San and 1 152 unrelated 
healthy black Africans from southern, western and central 
Africa. In southern African black groups, eight 3120+1G       A 
heterozygotes were found out of 728 subjects, giving a carrier 
frequency for this mutation of 1 in 91 (1.1%, 95% confidence 
interval (CI) 0.51 - 2.17%).
   Given this prevalence, surprisingly few cases have been 
diagnosed.  Is CF different in black African patients or is it 
not being thought of in patients with suggestive symptoms 
in South Africa’s health services?  Padoa and colleagues4 
suggested that black African CF cases might be dying 
diagnosed as having had malnutrition or pneumonia. The 
following sequence of 5 case reports from the Red Cross War 
Memorial Children’s Hospital (RCCH) in Cape Town over 20 
years illustrates the evolution of understanding of clinical CF 
among black Africans in South Africa.
Case 1: ‘Cystic fibrosis unlikely 
because of race’, 1984
This child of a Xhosa-speaking mother presented at 2 
months of age with anaemia and growth faltering.  She was 
hypoproteinaemic and had a lower respiratory tract infection 
with peripheral airways obstruction.  Weight gain in hospital 
was very poor and the respiratory infection persisted.  
Gastro-oesophageal reflux (GOR) was demonstrated.  She 
was readmitted a month after discharge with another chest 
infection.  A diagnosis of early kwashiorkor was also made. 
GOR was thought to be a significant factor in her chest disease 
although a pH study was negative. In view of persistent 
poor weight gain and chest signs a sweat test was performed 
(Table I). As this was abnormal, it was repeated.  Tests for 
malabsorption were undertaken: fat globules were seen, tryptic 
activity was normal, and faecal fat testing was unsuccessful. 
The gastroenterology team felt that the child’s ethnic origin 
made CF unlikely. She stayed in hospital for 6 months, 
gaining some weight on an elemental formula.  By the time 
of discharge, 5 positive sweat tests had been obtained. After 
a 6th positive test, the CF clinic followed up the case but was 
unwilling to give a definitive CF diagnosis. Two more sweat 
tests were positive (Table I).  At 2½ years of age, the child 
rapidly succumbed to a severe respiratory infection. Autopsy 
demonstrated a Pseudomonas pneumonia with air trapping. 
There were typical CF changes in the pancreas.
   This child never received a positive diagnosis of CF and 
therefore could not benefit from definitive treatment. The 
diagnosis was proved by postmortem examination but was not 
taken further by way of family studies. A subsequent offer of 
genetic testing was turned down by the child’s mother.  
Case 2: ‘Do a sweat test’, 1993
This child presented at 3 months of age with pneumonia and 
failure to gain weight.  His mother was Xhosa-speaking.  His 
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Table I. Sweat test results for case 1
Sweat sodium Sweat chloride Sweat mass
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father, said to be from the same group, had been murdered.  
Tests for tuberculosis (TB) were done and follow-up was 
arranged. The child presented soon afterwards with collapsed 
right middle and left lower lobes and severe air trapping.  
There was some response to broad-spectrum antibiotics 
but severe peripheral airways obstruction persisted. A 
pulmonologist requested a sweat test.  The ward staff viewed 
this suggestion with incredulity but went ahead. The result 
was positive (sweat mass 77 mg, sodium (Na) 78 mmol/l, 
chloride (Cl) 114 mmol/l), as was a second test (sweat mass 153 
mg, Na 94 mmol/l, Cl 104 mmol/l). Because he was a black 
African child, a third test was requested. It was also positive 
(sweat mass 299 mg Na 83 mmol/l, Cl 103 mmol/l). Molecular 
testing by the Department of Genetics at the South African 
Institute of Medical Research/National Health Laboratory 
Services (SAIMR/NHLS) in Johannesburg, with the help of 
colleagues in France, identified 2 CFTR mutations.  One was 
the ‘African mutation’, 3120+1G      A, and the other was a 
unique mutation, 3196del54.3 This child has shown a typical CF 
course with pancreatic insufficiency and Staphylococcus aureus 
and mucoid P. aeruginosa in the chest.  He was 13 years old at 
the time of writing.
   Case 3 now benefited from the RCCH’s experience with CF 
in the Xhosa-speaking population.
Case 3: ‘Not HIV, so what is the cause 
of the problem?’, 1995
This infant, born in King Williamstown to Xhosa-speaking 
parents, had not grown since birth and was severely wasted.  
He had persistent changes on his chest radiograph, with 
marked air trapping. He had a firm hepatomegaly. He had 
been investigated for TB and HIV infection, with repeated 
negative results in Port Elizabeth and was transferred to 
RCCH for further testing. CF seemed likely despite the child’s 
ethnicity and was proved within a few days – 2 sweat tests 
were positive (test 1: sweat mass 371 mg, Na 80 mmol/l, Cl 
107 mmol/l; test 2: sweat mass 356 mg, Na 82 mmol/l, Cl 99 
mmol/l), there was a high faecal fat level, and mucoid   
P. aeruginosa and S. aureus were grown from the sputum. The 
3120+1G       A mutation was not present.
   This case, following hard on the heels of case 2, was rapidly 
diagnosed at RCCH. The child’s diagnosis brought the message 




This male child of Xhosa-speaking parents presented at 
age 2 years with repeated pneumonia and failure to thrive 
from 9 months of age. Investigations for TB and HIV were 
negative. He had had diarrhoea intermittently from infancy. 
On admission he had lung hyperinflation and respiratory 
distress. Chest radiograph confirmed air trapping and there 
were opacifications in the right upper lobe and perihilar 
regions. Sweat chloride was 52 mmol/l. Repeat tests showed 
variable (but abnormal) results (test 2: sweat mass 209 mg, Na 
101 mmol/l, Cl 94 mmol/l; test 3: mass 220 mg, Na 53 mmol/l, 
Cl 45 mmol/l).  Tests for fat malabsorption were unsuccessful. 
Mutation analysis covering common South African mutations 
including 3120+1G       A was negative.  CF was thought 
probable but was not proved. With a respiratory infection 2 
months later, mucoid P. aeruginosa was grown from his sputum, 
increasing the likelihood of CF. The patient was treated with 
pancreatic enzyme supplementation, nutritional advice and 
physiotherapy. A year later, during which time he had had a 
few mild respiratory infections and had gained weight, a 4th 
sweat test was again equivocal (test 4: sweat mass 265 mg, Na 
56 mmol/l, Cl 55 mmol/l). His radiograph showed persistent 
air trapping and perihilar infiltrates.  
   With this patient, CF in black Africans joined the mainstream 
– recurrent chest infections leading to an investigation of CF 
and a complex of suggestive symptoms and test results but 




This male infant of Xhosa-speaking parents presented at 
2 months of age with dehydration and diarrhoea.  There 
were no chest signs or symptoms and no significant family 
history.  Investigation revealed a hypochloraemic metabolic 
alkalosis.  Sweat tests were requested by junior doctors in the 
Rehydration Unit and the diagnosis of CF was confirmed. 
Mutation analysis showed the child to be a compound 
heterozygote with 1 copy of the 3120+1G       A mutation.
   This encouraging case illustrates that CF is part of the 
differential diagnosis of all children, irrespective of ethnic 
origin, presenting with suggestive features in contemporary 
Cape Town. The challenge presented 22 years ago when case 
1 was born has begun to be met – CF occurs in black Africans 
and is being considered in appropriate clinical situations by 
non-experts.  
   Since this article was written, a 6th child, presenting with 
respiratory signs and growth faltering, has been diagnosed at 7 
weeks of age.
   The authors gratefully acknowledge the help of professors 
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